These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 11747277
1. Intravenously administered pamidronate in the treatment of Paget's disease of bone. Tucci JR, Bontha S. Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277 [Abstract] [Full Text] [Related]
2. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels. Ang G, Feiglin D, Moses AM. Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571 [Abstract] [Full Text] [Related]
7. Clinical experience with pamidronate in the treatment of Paget's disease of bone. Gallacher SJ, Boyce BF, Patel U, Jenkins A, Ralston SH, Boyle IT. Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163 [Abstract] [Full Text] [Related]
8. High-dose pamidronate in the management of resistant Paget's disease. Cundy T, Wattie D, King AR. Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232 [Abstract] [Full Text] [Related]
10. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH. Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907 [Abstract] [Full Text] [Related]
11. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment. Laroche M, Delpech B, Bernard J, Constantin A, Mazières B. Calcif Tissue Int; 1999 Sep; 65(3):188-91. PubMed ID: 10441648 [Abstract] [Full Text] [Related]
12. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Thiébaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P. Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129 [Abstract] [Full Text] [Related]
13. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. Ryan PJ, Gibson T, Fogelman I. J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830 [Abstract] [Full Text] [Related]
14. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone. Cantrill JA, Buckler HM, Anderson DC. Ann Rheum Dis; 1986 Dec; 45(12):1012-8. PubMed ID: 3813665 [Abstract] [Full Text] [Related]
15. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?]. Wilczek H. Cas Lek Cesk; 1997 Dec 03; 136(23):730-2. PubMed ID: 9476376 [Abstract] [Full Text] [Related]
16. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V. Calcif Tissue Int; 2004 Sep 03; 75(3):189-96. PubMed ID: 15148558 [Abstract] [Full Text] [Related]
17. Single-day intravenous pamidronate in Paget's disease. Hooper MJ, Clifton-Bligh P, Marel GM, Lang FV, Tancred J, McDowall D, Forman L. Semin Arthritis Rheum; 1994 Feb 03; 23(4):276-7. PubMed ID: 8009255 [Abstract] [Full Text] [Related]
18. [A single infusion of Pamidronate (APD) in Paget's disease of bone]. Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P. Schweiz Med Wochenschr; 1989 Jan 21; 119(3):71-4. PubMed ID: 2711157 [Abstract] [Full Text] [Related]